Eagle Pharmaceuticals, Inc. Financial and Nonfinancial Liabilities, Fair Value Disclosure
Eagle Pharmaceuticals, Inc. had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $0 as of 2020-09-30, per its 10-Q filed 2020-11-02.
Discontinued › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis › Fair Value, Net Asset (Liability)
us-gaap:LiabilitiesFairValueDisclosure · last filed 2020-11-02
- 2020-09-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $0.00.
- 2019-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $0.00.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure |
|---|---|
| 2020-09-30 | $0.00 10-Q · filed 2020-11-02 |
| 2019-12-31 | $0.00 10-Q · filed 2020-11-02 |